Segn el comunicado de la FDA, el GLP-1 en dosis ms altas est indicado para reducir el exceso de peso corporal y mantener la prdida de peso a largo plazo en adultos con obesidad o sobrepeso que padezcan al menos una afeccin relacionada con el peso
Medication is only one part of a responsible program
On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B outsourcing facility bulks list, finding no clinical need for large-scale compounding of these medications from bulk substances
Some users describe flavors becoming stronger or unpleasant while on the medications, though individual experiences seem to vary: Siobhan, a Los Angelesbased writer, who has been taking Wegovy since 2021 and withheld her last name for privacy, says she still finds fatty foods such as French fries appealingbut her favorite food, panang curry, has become too bitter
Patients often report improvements in conditions associated with excess body fat, such as lower cholesterol, blood pressure, and blood sugar levels